Table:
begin	end	state
1	12	non-cytoplasmic
13	41	transmembrane
42	73	cytoplasmic
74	92	transmembrane
93	111	non-cytoplasmic
112	142	transmembrane
143	153	cytoplasmic
154	181	transmembrane
182	191	non-cytoplasmic
192	213	transmembrane
214	231	cytoplasmic
232	253	transmembrane
254	264	non-cytoplasmic
265	283	transmembrane
284	295	cytoplasmic
296	316	transmembrane
317	327	non-cytoplasmic
328	350	transmembrane
351	356	cytoplasmic
357	375	transmembrane
376	394	non-cytoplasmic
395	422	transmembrane
423	439	cytoplasmic
440	462	transmembrane
463	466	non-cytoplasmic

Input:
>GFF1282 FitnessBrowser__Phaeo:GFF1282
MEPIEIGLWVSGFLLATVLLGMRVAFAAGLAGLVGLVWIFWAKFGYDPERFTKAVTIAVK
TAGQVPHSKVSSQALSLIPTFILIGYLAYYAGLTKALFEAAKRWLAWVPGGLAVSTVFAT
AGFAAVSGASVATSAVFARIAIPEMLKIGYDKRFAAGVVAAGGTLASLIPPSAILVIYAI
IVEQDVGKLLLAGFIPGAFSAVVYGLLIIGMAMTIKGFGPAVTGFTWKERLVSLPPALPI
LFVVATIILFVYNPFGGDAWGTPTEGGAIGAFVVFLMALYRGMRWAELKDALLETAKLSV
MIFTIIWGVLIYVRFLGFAELPAAFSDWITSLTLSPMLILICILLAYAVLGMFMDAIGML
LLTLPVVYPAVMALNGGEYVSAAESTFGMSGPMCAIWFGILVVKMAEFCLITPPIGLNCF
VVAGVRDDLTVQDVFKGVTPFFIADGITIAILVAFPSIVLWLPSLA

Or try the official Phobius web server, which has a different display

Reference: Advantages of combined transmembrane topology and signal peptide prediction - the Phobius web server